The market size and future development trend of China's pharmaceutical intermediate industry

China's pharmaceutical intermediate industry is an important part of China's pharmaceutical industry and an important force in promoting the development of China's pharmaceutical industry.In recent years, with the development of China's pharmaceutical industry, China's pharmaceutical intermediate industry has also made great strides.

　　According to the analysis of the investment strategy analysis and development positioning research report of China's pharmaceutical intermediate industry from 2023 to 2029 published by Market Research Online, as of 2018, the total scale of China's pharmaceutical intermediate industry reached 71.75 billion yuan, of which the industry's sales revenue reached 64.74 billion yuan.Among these revenues, the revenue from chemical raw materials was the highest, reaching 42.66 billion yuan, accounting for about 66%; the revenue from synthetic drugs was the second, reaching 20.19 billion yuan, accounting for about 31%; other revenue was relatively small, only 1.89 billion yuan, accounting for about 3%.

　　As China's pharmaceutical market continues to develop and grow, China's pharmaceutical intermediate industry will also continue to develop.It is expected that by 2025, the total scale of China's pharmaceutical intermediates industry will reach 149.32 billion yuan, an increase of about 106.3% over 2018, of which the industry's sales revenue will also reach 131.72 billion yuan, an increase of about 103.2% over 2018.In addition, with the development of the market, the proportion of various drugs will also change.It is expected that by 2025, the revenue of chemical raw materials will reach 73.33 billion yuan, accounting for about 56.1%; while the revenue of synthetic drugs will reach 50.63 billion yuan, accounting for about 38.4%; other revenue will be 7.76 billion yuan, accounting for about 5.9%.

　　As can be seen from the above, the market size of China's pharmaceutical intermediate industry is constantly growing, and the future development prospects are also very optimistic.In the next few years, China's pharmaceutical intermediate industry will continue to maintain rapid growth, and the proportion of various drugs will also change, making positive contributions to the development of China's entire pharmaceutical industry.